BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen L, Brenner DA, Kisseleva T. Combatting Fibrosis: Exosome-Based Therapies in the Regression of Liver Fibrosis. Hepatol Commun. 2018;3:180-192. [PMID: 30766956 DOI: 10.1002/hep4.1290] [Cited by in Crossref: 29] [Cited by in F6Publishing: 41] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Lucotti S, Kenific CM, Zhang H, Lyden D. Extracellular vesicles and particles impact the systemic landscape of cancer. EMBO J 2022;:e109288. [PMID: 36052513 DOI: 10.15252/embj.2021109288] [Reference Citation Analysis]
2 Marrero E, Attal N, Nimeri A, McGee RM, Benbow JH, Thompson KJ, Schrum LW, McKillop IH. Ectodysplasin-A mRNA in exosomes released from activated hepatic stellate cells stimulates macrophage response. Exp Cell Res 2022;419:113297. [PMID: 35964664 DOI: 10.1016/j.yexcr.2022.113297] [Reference Citation Analysis]
3 Salehipour Bavarsad S, Jalali MT, Bijan Nejad D, Alypoor B, Babaahmadi Rezaei H, Mohammadtaghvaei N. TGFβ1-Pretreated Exosomes of Wharton Jelly Mesenchymal Stem Cell as a Therapeutic Strategy for Improving Liver Fibrosis. Hepat Mon 2022;22. [DOI: 10.5812/hepatmon-123416] [Reference Citation Analysis]
4 Safran M, Masoud R, Sultan M, Tachlytski I, Chai Gadot C, Pery R, Balint-Lahat N, Pappo O, Buzaglo N, Ben-Ari Z. Extracellular Vesicular Transmission of miR-423-5p from HepG2 Cells Inhibits the Differentiation of Hepatic Stellate Cells. Cells 2022;11:1715. [PMID: 35626751 DOI: 10.3390/cells11101715] [Reference Citation Analysis]
5 El-Fadaly AA, Afifi NA, El-Eraky W, Salama A, Abdelhameed MF, El-Rahman SSA, Ramadan A. Fisetin alleviates thioacetamide-induced hepatic fibrosis in rats by inhibiting Wnt/β-catenin signaling pathway. Immunopharmacol Immunotoxicol 2022;:1-12. [PMID: 35255766 DOI: 10.1080/08923973.2022.2047198] [Reference Citation Analysis]
6 Gu L, Zhang F, Wu J, Zhuge Y. Nanotechnology in Drug Delivery for Liver Fibrosis. Front Mol Biosci 2022;8:804396. [DOI: 10.3389/fmolb.2021.804396] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Castillo-Castro C, Martagón-Rosado AJ, Ortiz-Lopez R, Garrido-Treviño LF, Villegas-Albo M, Bosques-Padilla FJ. Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome. World J Hepatol 2021; 13(11): 1494-1511 [PMID: 34904026 DOI: 10.4254/wjh.v13.i11.1494] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Fagoonee S, Arigoni M, Manco M, Olivero M, Bizzaro F, Magagnotti C, Andolfo A, Miniscalco B, Forni M, Todeschi S, Tolosano E, Bocchietto E, Calogero RA, Altruda F. Circulating extracellular vesicles contain liver-derived RNA species as indicators of severe cholestasis-induced early liver fibrosis in mice. Antioxid Redox Signal 2021. [PMID: 34779230 DOI: 10.1089/ars.2021.0023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Liu T, Chen S, Xie X, Liu H, Wang Y, Qi S, Shi L, Zhou X, Zhang J, Wang S, Wang Y, Chen S, Dou S, Jiang X, Cui R, Jiang H. Soluble TREM-1, as a new ligand for the membrane receptor Robo2, promotes hepatic stellate cells activation and liver fibrosis. J Cell Mol Med 2021. [PMID: 34750987 DOI: 10.1111/jcmm.17033] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Tang R, Li R, Li H, Ma XL, Du P, Yu XY, Ren L, Wang LL, Zheng WS. Design of Hepatic Targeted Drug Delivery Systems for Natural Products: Insights into Nomenclature Revision of Nonalcoholic Fatty Liver Disease. ACS Nano 2021. [PMID: 34705426 DOI: 10.1021/acsnano.1c02158] [Reference Citation Analysis]
11 Caligiuri A, Gentilini A, Pastore M, Gitto S, Marra F. Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression. Cells 2021;10:2759. [PMID: 34685739 DOI: 10.3390/cells10102759] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
12 Peng Y, Li Z, Chen S, Zhou J. DHFR silence alleviated the development of liver fibrosis by affecting the crosstalk between hepatic stellate cells and macrophages. J Cell Mol Med 2021;25:10049-60. [PMID: 34626074 DOI: 10.1111/jcmm.16935] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Ji Y, Luo Z, Gao H, Dos Reis FCG, Bandyopadhyay G, Jin Z, Manda KA, Isaac R, Yang M, Fu W, Ying W, Olefsky JM. Hepatocyte-derived exosomes from early onset obese mice promote insulin sensitivity through miR-3075. Nat Metab 2021;3:1163-74. [PMID: 34489604 DOI: 10.1038/s42255-021-00444-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
14 Hou X, Yin S, Ren R, Liu S, Yong L, Liu Y, Li Y, Zheng MH, Kunos G, Gao B, Wang H. Myeloid-Cell-Specific IL-6 Signaling Promotes MicroRNA-223-Enriched Exosome Production to Attenuate NAFLD-Associated Fibrosis. Hepatology 2021;74:116-32. [PMID: 33236445 DOI: 10.1002/hep.31658] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 27.0] [Reference Citation Analysis]
15 Neshat SY, Quiroz VM, Wang Y, Tamayo S, Doloff JC. Liver Disease: Induction, Progression, Immunological Mechanisms, and Therapeutic Interventions. Int J Mol Sci 2021;22:6777. [PMID: 34202537 DOI: 10.3390/ijms22136777] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
16 Kartasheva-Ebertz DM, Pol S, Lagaye S. Retinoic Acid: A New Old Friend of IL-17A in the Immune Pathogeny of Liver Fibrosis. Front Immunol 2021;12:691073. [PMID: 34211477 DOI: 10.3389/fimmu.2021.691073] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
17 Guo W, Guo T, Zhou Q, Long Y, Luo M, Shen Q, Duan W, Ouyang X, Peng H. Cofilin-1 promotes fibrocyte differentiation and contributes to pulmonary fibrosis. Biochem Biophys Res Commun 2021;565:43-9. [PMID: 34090209 DOI: 10.1016/j.bbrc.2021.05.085] [Reference Citation Analysis]
18 Zhu YZ, Hu X, Zhang J, Wang ZH, Wu S, Yi YY. Extracellular Vesicles Derived From Human Adipose-Derived Stem Cell Prevent the Formation of Hypertrophic Scar in a Rabbit Model. Ann Plast Surg 2020;84:602-7. [PMID: 32282497 DOI: 10.1097/SAP.0000000000002357] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
19 Wang X, He Y, Mackowiak B, Gao B. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. Gut 2021;70:784-95. [PMID: 33127832 DOI: 10.1136/gutjnl-2020-322526] [Cited by in Crossref: 79] [Cited by in F6Publishing: 92] [Article Influence: 79.0] [Reference Citation Analysis]
20 Mao Y, Jacob V, Singal A, Lei S, Park MS, Lima MRN, Li C, Dhall S, Sathyamoorthy M, Kohn J. Exosomes Secreted from Amniotic Membrane Contribute to Its Anti-Fibrotic Activity. Int J Mol Sci 2021;22:2055. [PMID: 33669673 DOI: 10.3390/ijms22042055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Kiseleva YV, Zharikov YO, Maslennikov RV, Pavlov CS, Nikolenko VN. Molecular factors associated with regression of liver fibrosis of alcoholic etiology. Terapevticheskii arkhiv 2021;93:204-8. [DOI: 10.26442/00403660.2021.02.200617] [Reference Citation Analysis]
22 Gratte FD, Pasic S, Abu Bakar NDB, Gogoi-Tiwari J, Liu X, Carlessi R, Kisseleva T, Brenner DA, Ramm GA, Olynyk JK, Tirnitz-Parker JEE. Previous liver regeneration induces fibro-protective mechanisms during thioacetamide-induced chronic liver injury. Int J Biochem Cell Biol 2021;134:105933. [PMID: 33540107 DOI: 10.1016/j.biocel.2021.105933] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Ganguly N, Chakrabarti S. Role of long non‑coding RNAs and related epigenetic mechanisms in liver fibrosis (Review). Int J Mol Med 2021;47:23. [PMID: 33495817 DOI: 10.3892/ijmm.2021.4856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
24 Hung C. Origin of Myofibroblasts in Lung Fibrosis. Curr Tissue Microenviron Rep 2020;1:155-62. [DOI: 10.1007/s43152-020-00022-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
25 Alfonso García SL, Parada-Sanchez MT, Arboleda Toro D. The phenotype of gingival fibroblasts and their potential use in advanced therapies. Eur J Cell Biol 2020;99:151123. [PMID: 33070040 DOI: 10.1016/j.ejcb.2020.151123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Feng D, Gerarduzzi C. Emerging Roles of Matricellular Proteins in Systemic Sclerosis. Int J Mol Sci 2020;21:E4776. [PMID: 32640520 DOI: 10.3390/ijms21134776] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Zehra M, Curry JC, Pillai SS, Lakhani HV, Edwards CE, Sodhi K. Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis. Int J Mol Sci 2020;21:E4737. [PMID: 32635162 DOI: 10.3390/ijms21134737] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
28 Popowski K, Lutz H, Hu S, George A, Dinh PU, Cheng K. Exosome therapeutics for lung regenerative medicine. J Extracell Vesicles 2020;9:1785161. [PMID: 32944172 DOI: 10.1080/20013078.2020.1785161] [Cited by in Crossref: 16] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
29 Shen C, Huang XY, Geng CA, Li TZ, Tang S, Su LH, Gao Z, Zhang XM, Hu J, Chen JJ. Artemlavanins A and B from Artemisia lavandulaefolia and Their Cytotoxicity Against Hepatic Stellate Cell Line LX2. Nat Prod Bioprospect 2020;10:243-50. [PMID: 32583278 DOI: 10.1007/s13659-020-00254-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
30 Piazzolla VA, Mangia A. Noninvasive Diagnosis of NAFLD and NASH. Cells 2020;9:E1005. [PMID: 32316690 DOI: 10.3390/cells9041005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 58] [Article Influence: 13.5] [Reference Citation Analysis]
31 Hernández A, Arab JP, Reyes D, Lapitz A, Moshage H, Bañales JM, Arrese M. Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy. Cells 2020;9:E817. [PMID: 32231001 DOI: 10.3390/cells9040817] [Cited by in Crossref: 11] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
32 Abo-Zaid MA, Shaheen ES, Ismail AH. Immunomodulatory effect of curcumin on hepatic cirrhosis in experimental rats. J Food Biochem 2020;44:e13219. [PMID: 32215945 DOI: 10.1111/jfbc.13219] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
33 He Z, Yang D, Fan X, Zhang M, Li Y, Gu X, Yang M. The Roles and Mechanisms of lncRNAs in Liver Fibrosis. Int J Mol Sci 2020;21:E1482. [PMID: 32098245 DOI: 10.3390/ijms21041482] [Cited by in Crossref: 11] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
34 Chen L, Yao X, Yao H, Ji Q, Ding G, Liu X. Exosomal miR-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells. FASEB J. 2020;34:5178-5192. [PMID: 32061112 DOI: 10.1096/fj.201902307rrr] [Cited by in Crossref: 22] [Cited by in F6Publishing: 40] [Article Influence: 11.0] [Reference Citation Analysis]
35 Han HS, Lee H, You D, Nguyen VQ, Song DG, Oh BH, Shin S, Choi JS, Kim JD, Pan CH, Jo DG, Cho YW, Choi KY, Park JH. Human adipose stem cell-derived extracellular nanovesicles for treatment of chronic liver fibrosis. J Control Release 2020;320:328-36. [PMID: 31981658 DOI: 10.1016/j.jconrel.2020.01.042] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
36 Li L, Yang C, Yang J, Li H, Zhang B, Zhou H, Hu S, Wang K, Huang C, Meng X, Zhou H, Zhang L, Li J, Xu T. ZEB1 regulates the activation of hepatic stellate cells through Wnt/β-catenin signaling pathway. European Journal of Pharmacology 2019;865:172787. [DOI: 10.1016/j.ejphar.2019.172787] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
37 Zhangdi HJ, Su SB, Wang F, Liang ZY, Yan YD, Qin SY, Jiang HX. Crosstalk network among multiple inflammatory mediators in liver fibrosis. World J Gastroenterol 2019; 25(33): 4835-4849 [PMID: 31543677 DOI: 10.3748/wjg.v25.i33.4835] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 28] [Article Influence: 9.7] [Reference Citation Analysis]
38 Chong SG, Sato S, Kolb M, Gauldie J. Fibrocytes and fibroblasts-Where are we now. Int J Biochem Cell Biol 2019;116:105595. [PMID: 31473260 DOI: 10.1016/j.biocel.2019.105595] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 8.7] [Reference Citation Analysis]
39 Meurer S, Wimmer AE, Leur EV, Weiskirchen R. Endoglin Trafficking/Exosomal Targeting in Liver Cells Depends on N-Glycosylation. Cells 2019;8:E997. [PMID: 31466384 DOI: 10.3390/cells8090997] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
40 Aller MA, Blanco-Rivero J, Arias N, Santamaria L, Arias J. The Lymphatic Headmaster of the Mast Cell-Related Splanchnic Inflammation in Portal Hypertension. Cells 2019;8:E658. [PMID: 31261968 DOI: 10.3390/cells8070658] [Reference Citation Analysis]
41 Zhang YZ, Yao JN, Zhang LF, Wang CF, Zhang XX, Gao B. Effect of NLRC5 on activation and reversion of hepatic stellate cells by regulating the nuclear factor-κB signaling pathway. World J Gastroenterol 2019; 25(24): 3044-3055 [PMID: 31293340 DOI: 10.3748/wjg.v25.i24.3044] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]